OPTIMIZE-2: Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery (clinicaltrials.gov) - Dec 10, 2024 - P3 | N=117 | Terminated | Sponsor: Oculis | Trial completion date: Dec 2024 ➔ May 2024 | Recruiting ➔ Terminated; Sponsor decision to close study due to third-party administrative error preventing analysis of trial results. There was no issue in terms of quality of the investigational product, and no safety risk to any study subject.
Surgery • Trial completion date • Trial termination • Cataract • Inflammation • Ocular Inflammation • Ophthalmology • Pain
|